Drug manufacturers make billions of dollars of profit each year despite the fact that prescription drugs are responsible for thousands of injuries each year. Drug makers have a duty to disclose known risks as well as risks they should know about. These risks include those that the drug companies should have known about through adequate testing and safety surveillance on patients taking their drugs.
If you feel that you have been injured by a prescription drug or medical device, please contact us for a free legal consultation to see if you may have a case.
Fosamax, also called alendronate sodium, as well as other drugs in the class of bisphosphonate drugs used to treat osteoporosis and osteopenia have been found to cause bone damage.
Pradaxa (dabigatran) is a prescription blood-thinning medication approved by the Food and Drug Administration (“FDA”) to reduce the risk of stroke in people with non-valvular atrial fibrillation.
The Associated Press revealed in July of 2005 that the risk of suffering from a blood clot while using the Ortho Evra birth control patch was three times higher than when using standard birth control pills.
The use of the prescription drug Zoloft has been linked to numerous birth defects, injuries, and other complications, particularly when used by pregnant women during their first trimester.
Millions of Americans use denture creams to keep their dentures securely in place. Zinc, contained in a number of popular adhesive creams, can cause copper deficiency in the user.
The FDA updated the Adverse Reactions section of the labeling for Singulair (Montelukast) in September 2012 to include Stevens-Johnson Syndrome (SJS).
Yaz is one of the brand names used for the generic drug drospirenone, also sold under the names Yasmine and Ocella.
Fox5DC is reporting that Kaiser Permanente in Largo, Maryland has exposed 23 patients to HIV, hepatitis C and other infections after failing to properly sterilize equipment. According to a statement released by Kaiser "a piece of endoscopy equipment at our Largo...
A research paper published last year by scientists at the Johns Hopkins Bloomberg School of Public Health provided further evidence of a connection between pregnant mothers use of certain type of medications, known as selective seratonin reuptake inhibitors or...